BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $342,000 | -37.8% | 40,700 | -14.6% | 0.01% | -36.4% |
Q3 2017 | $550,000 | +16.0% | 47,650 | +17.4% | 0.01% | 0.0% |
Q2 2017 | $474,000 | +7.2% | 40,600 | +13.2% | 0.01% | 0.0% |
Q1 2017 | $442,000 | -10.0% | 35,850 | -0.6% | 0.01% | 0.0% |
Q4 2016 | $491,000 | +16266.7% | 36,050 | +16667.4% | 0.01% | – |
Q3 2015 | $3,000 | -25.0% | 215 | 0.0% | 0.00% | – |
Q2 2015 | $4,000 | – | 215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 1,026,402 | $21,832,000 | 2.20% |
Avoro Capital Advisors LLC | 262,515 | $5,584,000 | 1.54% |
Lamond Capital Partners LLC | 68,780 | $1,463,000 | 1.48% |
Green Owl Capital Management, LLC | 90,000 | $1,914,000 | 1.36% |
Baker Brothers Advisors | 4,190,594 | $89,134,000 | 0.78% |
SPHERA FUNDS MANAGEMENT LTD. | 231,514 | $4,924,000 | 0.48% |
Redmile Group, LLC | 238,121 | $5,065,000 | 0.42% |
Highlander Capital Management, LLC | 19,250 | $409,000 | 0.37% |
Spark Investment Management LLC | 110,500 | $2,350,000 | 0.33% |
EMERALD MUTUAL FUND ADVISERS TRUST | 145,380 | $3,092,000 | 0.24% |